Á lódáil...

Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent

BACKGROUND: Although the clinical outcome of patients with diffuse large B cell lymphoma (DLBCL) has been improved by the addition of rituximab to standard chemotherapy, almost one-third fails or relapses after first line treatment. The presence of monoclonal gammopathy (MG) is a known adverse progn...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Exp Hematol Oncol
Main Authors: Mondello, Patrizia, Pitini, Vincenzo, Barresi, Valeria, Brea, Elliott Joseph, Di Mirto, Cristian, Arrigo, Carmela, Cuzzocrea, Salvatore, Mian, Michael
Formáid: Artigo
Teanga:Inglês
Foilsithe: BioMed Central 2016
Ábhair:
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4702294/
https://ncbi.nlm.nih.gov/pubmed/26740908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-015-0030-1
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!